Diabetes dose selection
Sitagliptin renal dosing: the boundary is part of the answer
Januvia renal dosing depends on an eGFR band, not a vague description of kidney disease. Read the boundary carefully and keep dose selection separate from the decision about whether the medicine is appropriate.
Sources checked October 11, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Use the actual eGFR rather than a disease label
The standard Januvia dose is 100 mg once daily. For eGFR at least 45 but below 90, no adjustment is required. For eGFR at least 30 but below 45, use 50 mg once daily. For eGFR below 30 or ESRD requiring dialysis, use 25 mg once daily.
At exactly 45, the patient is in the no-adjustment group. At exactly 30, the patient is in the 50 mg group. Words such as moderate or severe are useful descriptions, but the numerical boundary controls the label-based answer.
Check when the kidney result was obtained
Assess renal function before initiation and periodically thereafter. A dose chosen from an old result may no longer match a changing clinical situation. A question that gives several results requires identifying the relevant current value, not selecting the first number on the page.
A declining eGFR needs review of the medicine regimen and the underlying illness. This lesson does not provide a rule for estimating renal function during unstable acute illness. Use clinical assessment rather than assuming every reported value is interchangeable.
Do not invent a post-dialysis replacement dose
The label says Januvia may be administered without regard to dialysis timing in ESRD. The 25 mg once-daily regimen is not an instruction to add another dose after a session. A familiar dialysis-supplement pattern for another drug should not be copied here.
Keep the drug name and regimen attached to the instruction. If a case includes missed doses or uncertain adherence, resolve that separately rather than treating dialysis as an automatic reason for replacement.
Keep adverse-effect assessment separate from arithmetic
The label describes pancreatitis, serious hypersensitivity, severe arthralgia and bullous pemphigoid among the safety concerns. Hypoglycemia risk can increase when sitagliptin is combined with insulin or a secretagogue. A correct renal dose does not prove the whole regimen is safe.
For exam reasoning, give the dose band and then identify any independent warning in the case. Do not use a successful numerical adjustment as a reason to ignore persistent severe abdominal pain or a serious reaction.
A worked case
A patient has current eGFR 30 and takes Januvia 100 mg daily. A learner chooses 25 mg because they interpreted the lowest moderate-impairment value as severe impairment. Which boundary has been read incorrectly?
- The 50 mg band includes eGFR exactly 30.
- The 25 mg band is below 30 or ESRD.
- Renal function should continue to be assessed rather than treating a borderline value as permanent.
Answer: For the stated stable eGFR of 30, the label-based dose is 50 mg once daily, subject to the actual clinical prescribing review.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Which band includes exactly 45?
The no-adjustment band: 100 mg once daily.
2. Which band includes exactly 30?
50 mg once daily.
3. Does ESRD require an extra post-dialysis dose?
No. The label allows the 25 mg daily dose without regard to dialysis timing.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.